University Of Cambridge

Blood thinning drug to treat recovery from COVID-19 is not effective

Blood thinning drug to treat recovery from COVID-19 is not effective

A Blood thinning drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge has found.  The HEAL-COVID trial (Helping to Alleviate the Longer-term consequences of COVID-19) is

Blood thinning drug to treat recovery from COVID-19 is not effective Read More »

Well-being of young people falls in first years of secondary school

Well-being of young people falls in first years of secondary school

Most young people in the UK experience a sharp decline in their subjective well-being during their first years at secondary school, regardless of their circumstances or background, new research shows.  Academics from the Universities of Cambridge and Manchester analysed the well-being and self-esteem of more than 11,000 young people from across the UK, using data

Well-being of young people falls in first years of secondary school Read More »

Feeling poorer in early adolescence is associated with mental health

Feeling poorer in early adolescence is associated with worse mental health

Feeling poorer than your friends in early adolescence is associated with worse mental health says study  Young people who believe they come from poorer backgrounds than their friends are more likely to have lower self-esteem and be victims of bullying than those who feel financially equal to the rest of their peer group, according to

Feeling poorer in early adolescence is associated with worse mental health Read More »

First ever clinical trial of lab-grown red blood cell transfusion

First ever clinical trial of lab-grown red blood cell transfusion

Cambridge researchers are taking part in the world’s first clinical trial of red blood cell transfusion that have been grown in a laboratory for transfusion into another person.  “If our trial is successful, it will mean that patients who currently require regular long-term red blood cell transfusion will need fewer transfusions in future, helping transform

First ever clinical trial of lab-grown red blood cell transfusion Read More »